The city of Atlanta, Georgia, currently has 1 active clinical trials seeking participants for Atopic Dermatitis research studies.
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
Recruiting
This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
06/04/2024
Locations: AnaptysBio Investigative Site 10-122, Atlanta, Georgia
Conditions: Atopic Dermatitis Eczema